These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15764841)
1. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs. Nagasawa Y; Chen J; Hashimoto K J Pharmacol Sci; 2005 Mar; 97(3):393-9. PubMed ID: 15764841 [TBL] [Abstract][Full Text] [Related]
3. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs. Chen J; Xue Y; Eto K; Ni C; Hashimoto K J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885 [TBL] [Abstract][Full Text] [Related]
4. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. Manning AS; Bruyninckx C; Ramboux J; Chatelain P J Cardiovasc Pharmacol; 1995 Sep; 26(3):453-61. PubMed ID: 8583788 [TBL] [Abstract][Full Text] [Related]
5. Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias. Hashimoto K; Haruno A; Hirasawa A; Awaji T; Xue Y; Wu Z Jpn J Pharmacol; 1995 May; 68(1):1-9. PubMed ID: 7494370 [TBL] [Abstract][Full Text] [Related]
6. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165. Hashimoto K; Ishii M; Komori S; Mitsuhashi H Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models. Xue Y; Tanabe S; Nabuchi Y; Hashimoto K J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986 [TBL] [Abstract][Full Text] [Related]
8. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. Finance O; Manning A; Chatelain P J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217 [TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias. Hashimoto K; Akiyama K; Mitsuhashi H Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic effect of magnesium sulfate against occlusion-induced arrhythmias and reperfusion-induced arrhythmias in anesthetized rats. Komori S; Li B; Matsumura K; Takusagawa M; Sano S; Kohno I; Osada M; Sawanobori T; Ishihara T; Umetani K; Ijiri H; Tamura K Mol Cell Biochem; 1999 Sep; 199(1-2):201-8. PubMed ID: 10544968 [TBL] [Abstract][Full Text] [Related]
11. [Effects of combined amiodarone and antiarrhythmic peptide use on the cardiac gap junctions and incidence of induced ventricular arrhythmias in healed myocardial infarction rabbit models]. Li LD; Zhang CT; Ruan L; Ni MK; Fang Y; Wang GQ; Wang XF Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1102-7. PubMed ID: 21215147 [TBL] [Abstract][Full Text] [Related]
12. Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy. Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS J Pharmacol Exp Ther; 1981 Aug; 218(2):475-80. PubMed ID: 7252847 [TBL] [Abstract][Full Text] [Related]
13. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS Circulation; 1981 Jan; 63(1):70-9. PubMed ID: 7438409 [TBL] [Abstract][Full Text] [Related]
14. Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models. Xue Y; Yamada C; Chino D; Hashimoto K Eur J Pharmacol; 1999 Jul; 376(1-2):27-35. PubMed ID: 10440086 [TBL] [Abstract][Full Text] [Related]
15. Broad sensitivity of rodent arrhythmia models to class I, II, III, and IV antiarrhythmic agents. Brooks RR; Miller KE; Carpenter JF; Jones SM Proc Soc Exp Biol Med; 1989 Jun; 191(2):201-9. PubMed ID: 2726785 [TBL] [Abstract][Full Text] [Related]
16. Effects of a novel amiodarone-like compound SAR114646A on the pig atrium and susceptibility to ventricular fibrillation in dogs and pigs. Billman GE; Gögelein H; Ruetten H; Wirth KJ Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):373-84. PubMed ID: 22234329 [TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models. Mitsuhashi H; Akiyama K; Hashimoto K; Sawa Y; Hatori Y Jpn J Pharmacol; 1987 Jun; 44(2):155-62. PubMed ID: 3656773 [TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic effects of HOE642, a novel Na(+)-H+ exchange inhibitor, on ventricular arrhythmias in animal hearts. Xue YX; Aye NN; Hashimoto K Eur J Pharmacol; 1996 Dec; 317(2-3):309-16. PubMed ID: 8997615 [TBL] [Abstract][Full Text] [Related]
19. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide. Xue YX; Arita J; Aye NN; Hashimoto K Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724 [TBL] [Abstract][Full Text] [Related]
20. Amiodarone versus bretylium for suppression of reperfusion arrhythmias in dogs. Rosalion A; Snow NJ; Horrigan TP; Noon DL; Mostow ND Ann Thorac Surg; 1991 Jan; 51(1):81-5. PubMed ID: 1985582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]